跳到正文
原文
Nature Medicine· Karen O’Leary·· 22 天前AI 评分43

小分子TREM2激动剂VG-3927用于阿尔茨海默病

A small-molecule TREM2 agonist for Alzheimer’s disease

AI 导读

临床前分析和I期试验支持VG-3927作为阿尔茨海默病候选药物,显示其可穿透中枢神经系统、实现靶点结合并具耐受性。VG-3927为小分子TREM2激动剂,相关结果发表于Nature Medicine。

正文

Nature Medicine, Published online: 29 October 2026; doi:10.1038/d41591-026-00055-x

Preclinical analysis and a phase 1 trial support VG-3927 as a promising drug candidate for Alzheimer’s disease, demonstrating successful penetration of the central nervous system, target engagement and tolerability.

来源:Nature Medicine · nature.com